Global Ursodeoxycholic Acid Market, by Dosage Form (Liquid Dosage Form and Solid Dosage Form), by Mode of Extraction (Biological and Synthetic), by Application (Liver Cirrhosis, Gallstones, and Cystic Fibrosis), and by Region (North America, Asia Pacific, Latin America, Europe, Middle East, and Africa), had a market valuation of US$ 457.3 million in 2017 and is projected to exhibit a CAGR of 10.1% over the forecast period (2018 – 2026).
Get Sample Report with Latest Insights @
https://www.coherentmarketinsights.com/insight/request-sample/2199
Since UDCA is presently exclusively recommended in solid form, market participants may benefit from the development of liquid ursodeoxycholic acid. Patients who have trouble swallowing pills or capsules might benefit from the introduction of a liquid formulation of ursodeoxycholic acid, which would give healthcare practitioners with an alternative dosage option. The key companies in the market are concentrating their efforts on obtaining patents for UDCA liquid formulations. Retrophin, Inc. reached a formal deal with Asklepion Pharmaceuticals, LLC in June 2016 to buy the rights, titles, and ownership of a liquid formulation of ursodeoxycholic acid. Retrophin stated in 2017 that it would submit a new drug application (NDA) to the U.S. Food and Drug Administration (FDA) for a liquid formulation of ursodeoxycholic acid for the treatment of primary biliary cholangitis.
Browse 32 Market Data Tables and 22 Figures spread through 160 Pages and in-depth TOC on ‘Global Ursodeoxycholic Acid Market’- Global Forecast to 2026, by Dosage Form (Liquid Dosage Form and Solid Dosage Form), by Mode of Extraction (Biological and Synthetic), by Application (Liver Cirrhosis, Gallstones, and Cystic Fibrosis), and by Region (North America, Asia Pacific, Latin America, Europe, Middle East, and Africa)
Due to factors such as the high incidence of illnesses such as gallstones and liver cirrhosis, the Asia Pacific region is anticipated to dominate the global ursodeoxycholic acid market during the forecast period. According to figures provided by OMICS International, liver cirrhosis claimed the lives of 1.2 million Indians in 2013, up from 0.8 million in 1990. In addition, prominent businesses in the region are concentrating their efforts on obtaining permission for the development of ursodeoxycholic acid for novel indications. Non-ursodeoxycholic acid is being developed by EA Pharma in Japan for the treatment of primary sclerosing cholangitis (PSC) and non-alcoholic steatohepatitis (NASH).
Get PDF Brochure with Latest Insights @
https://www.coherentmarketinsights.com/insight/request-pdf/2199
Key Takeaways
Due to the research and development of innovative ursodeoxycholic acid, the global ursodeoxycholic acid market is anticipated to grow at a CAGR of 10.1 percent during the forecast period. The market is projected to expand due to the high frequency of illnesses such as gallstones and liver cirrhosis.
Due to the development of capsule and tablet forms of Ursodeoxycholic acid (UDCA) by various producers such as Grindex and Intercept Pharmaceuticals for the management of symptomatic biliary cholangitis, the solid dosage form segment dominated the global ursodeoxycholic acid market in 2018.
The gall stones category dominated the global ursodeoxycholic acid market in 2018, leading to an increase in the prevalence of the ailment. Gallstones impact 10-15% of the U.S. population each year or about 25 million individuals, according to a 2017 report by the American Gastroenterological Association.
Key companies contributing in the global ursodeoxycholic acid market are Zhongshan Belling Biotechnology Co., Mitsubishi Tanabe Pharma Corporation, Grindeks, Biotavia Labs Pvt Ltd, ERREGIERRE S.p.A., Dipharma Francis Srl, Suzhou Tianlu Bio-pharmaceutical Co., Ltd., PharmaZell GmbH, Daewoong Bio Inc., Industria Chimica Emiliana, Abil Chempharma Private Limited, and Glenmark Pharmaceutical Limited.
Reasons to Purchase this Report
• Current and future of global Ursodeoxycholic Acid market outlook in the developed and emerging markets
• The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
• Regions/countries that are expected to witness the fastest growth rates during the forecast period
• The latest developments, market shares, and strategies that are employed by the major market players
Table of Contents
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Dosage Form
- Market Snippet, By Mode of Extraction
- Market Snippet, By Application
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Market Trends
- PORTER’s Analysis
- Epidemiology
- Pipeline Analysis
- Market Dynamics
- Global Ursodeoxycholic Acid Market, By Dosage Form, 2016 – 2026, (US$ Mn)
- Introduction
- Market Share Analysis, 2016 and 2026 (%)
- Y-o-Y Growth Analysis, 2017 – 2026
- Segment Trends
- Solid Dosage Form
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- Liquid Dosage Form
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- Introduction
- Global Ursodeoxycholic Acid Market, By Mode of Extraction, 2016 – 2026, (US$ Mn)
- Introduction
- Market Share Analysis, 2016 and 2026 (%)
- Y-o-Y Growth Analysis, 2017 – 2026
- Segment Trends
- Synthetic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- Biological
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- Introduction
- Global Ursodeoxycholic Acid Market, By Application, 2016 – 2026, (US$ Mn)
- Introduction
- Market Share Analysis, 2016 and 2026 (%)
- Y-o-Y Growth Analysis, 2017 – 2026
- Segment Trends
- Gallstones
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- Cystic Fibrosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- Liver Cirrhosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- Introduction
- Global Ursodeoxycholic Acid Market, By Region, 2016 – 2026, (US$ Mn)
- Introduction
- Market Share Analysis, By Region, 2016 and 2026 (%)
- Y-o-Y Growth Analysis, For Regions, 2017–2026
- North America
- Market Size and Forecast, By Dosage Form, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Mode of Extraction, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Application, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
- U.S.
- Canada
- Latin America
- Market Size and Forecast, By Dosage Form, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Mode of Extraction, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Application, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Market Size and Forecast, By Dosage Form, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Mode of Extraction, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Application, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Dosage Form, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Mode of Extraction, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Application, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Market Size and Forecast, By Dosage Form, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Mode of Extraction, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Application, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast, By Dosage Form, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Mode of Extraction, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Application, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Country/Region, 2016 – 2026, (US$ Mn)
- South Africa
- Central Africa
- North Africa
- Introduction
- Competitive Landscape
- Heat Map Analysis
- Market Share Analysis
- Dipharma Francis Srl*
- Company Overview
- Dosage Form Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- ERREGIERRE S.p.A.
- Company Overview
- Dosage Form Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Grindeks
- Company Overview
- Dosage Form Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Industria Chimica Emiliana
- Company Overview
- Dosage Form Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Mitsubishi Tanabe Pharma Corporation
- Company Overview
- Dosage Form Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Zhongshan Belling Biotechnology Co.
- Company Overview
- Dosage Form Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Glenmark Pharmaceutical Limited
- Company Overview
- Dosage Form Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Abil Chempharma Private Limited
- Company Overview
- Dosage Form Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Biotavia Labs Pvt Ltd
- Company Overview
- Dosage Form Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Daewoong Bio Inc.
- Company Overview
- Dosage Form Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- PharmaZell GmbH
- Company Overview
- Dosage Form Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Suzhou Tianlu Bio-pharmaceutical Co., Ltd.
- Company Overview
- Dosage Form Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Dipharma Francis Srl*
- Analyst Views
- Section
- References
- Research Methodology
- About Us and Sales Contact
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
